To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery
NCT ID:
NCT06600503
Condition:
Pulmonary Rehabilitation
Telerehabilitation
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
pulmonary rehabilitation
mobile application
Telerehabilitation
Lung cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
RehabLung mobile application
Description:
Participants in the intervention group will receive in-person pulmonary rehabilitation
during their surgical admission and access to a mobile pulmonary rehabilitation
application for self-training. This program begins one month before surgery and continues
for seven weeks after surgery. The application is designed to encourage participants to
engage in pulmonary rehabilitation exercises from preoperative preparation through
postoperative care. It offers guided chest breathing exercises, using visual and movement
instructions created and remotely prescribed by a physical therapist. Participants will
receive daily breathing exercise prescriptions throughout the study period.
Arm group label:
application inttervention group
Other name:
The application group
Other name:
RehabLung App
Intervention type:
Behavioral
Intervention name:
Lung cancer postoperative standard care
Description:
Participants in the usual care group will receive in-person pulmonary rehabilitation
during surgical admission, pre-operative healthcare, and guidance on breathing exercises
to practice before surgery. They will also receive post-operative breathing exercise
prescriptions to follow at home.
Arm group label:
Usual care group
Other name:
usual care
Other name:
Standard chest rehabilitation
Intervention type:
Other
Intervention name:
Healthcare interactive Web Platform
Description:
The healthcare interactive Web Platform provides patients with surgical information
through animations. This includes an introduction to lung surgery, preparation
procedures, answers to common patient questions, post-surgery wound care, and a brief
guide to pulmonary rehabilitation.
Arm group label:
Usual care group
Arm group label:
application inttervention group
Summary:
The goal of this clinical trial is to investigate the effect of a mobile application
intervention on postoperative lung rehabilitation. The main purposes of this study are:
1. To understand the effectiveness of the pulmonary rehabilitation mobile application
in improving lung function.
2. To assess the feasibility of the pulmonary rehabilitation mobile application in
post-surgery rehabilitation care.
Researchers will compare the intervention group (using the pulmonary rehabilitation
mobile application) to the usual care group to determine if the mobile application is
effective in lung surgery rehabilitation.
Participants will join the study immediately after providing informed consent and will
continue for up to 7 weeks post-surgery. Participants will be randomly allocated to
either the intervention group or the control group. Both groups will receive regular
pulmonary rehabilitation during their hospital stay (1 day before surgery and 2 to 3 days
after surgery). Researchers will guide participants in the intervention group to use the
mobile application for pulmonary rehabilitation exercises throughout the study period.
Participants in the usual care group will receive health education and an exercise guide
before discharge. Participants will undergo three study assessments: at baseline (within
1 week after enrollment), post-surgery (week 5), and at follow-up (week 8).
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- age over 20 years
- primary diagnosis of lung cancer at any stage and type
- referral to lung cancer resection by thoracotomy or videothoracoscopy
- ability to understand and consent to the trial procedures
- conscious and cognition intact
Exclusion Criteria:
- included adjuvant treatments (chemotherapy or radiotherapy)
- previous history of thoracic surgery
- neurological and/or musculoskeletal comorbidities
- visual or hearing impairment
- acute respiratory illness
Gender:
All
Minimum age:
20 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
October 1, 2024
Completion date:
December 31, 2025
Lead sponsor:
Agency:
National Cheng Kung University
Agency class:
Other
Source:
National Cheng Kung University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06600503
